z-logo
open-access-imgOpen Access
Genomic and Immune Profiling of a Patient With Triple-Negative Breast Cancer That Progressed During Neoadjuvant Chemotherapy Plus PD-L1 Blockade
Author(s) -
David Casadevall,
Xiaotong Li,
Ryan L. Powles,
Vikram B. Wali,
Natália Buza,
Vasiliki Pelekanou,
Arjun Dhawan,
Julia Foldi,
Borbála Székely,
Francesc LópezGiráldez,
Christos Hatzis,
Lajos Pusztai
Publication year - 2019
Publication title -
jco precision oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.405
H-Index - 22
ISSN - 2473-4284
DOI - 10.1200/po.18.00335
Subject(s) - breast cancer , chemotherapy , blockade , triple negative breast cancer , medicine , oncology , neoadjuvant therapy , immune system , triple negative , cancer research , cancer , immunology , receptor

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom